Human CD30/TNFRSF8 (Research Grade Brentuximab Biosimilar) Antibody
Human CD30/TNFRSF8 (Research Grade Brentuximab Biosimilar) Antibody Summary
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Detection of CD30/TNFRSF8 in Jurkat human acute T cell leukemia cell line by Flow Cytometry. Jurkat human acute T cell leukemia cell line was stained with Human Anti-Human CD30/TNFRSF8 (Brentuximab Biosimilar) Monoclonal Antibody (Catalog # MAB9576, filled histogram) or irrelevant antibody (open histogram) followed by APC-conjugated Anti-Human IgG Secondary Antibody (Catalog # F0135). View our protocol for Staining Membrane-associated Proteins.
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Brentuximab is a biosimilar directed against the extracellular domain of CD30. This product constitutes the immunogen used for the anti-Idiotype catalog number MAB9584. The biotinylated antibody (catalog number FAB9576B) can be used in flow cytometry or various assay format to measure CD30 expression and can be detected by conjugated streptavidin.
Does this Biosimilar antibody have the same sequence as the therapeutic antibody?
The Biosimilar antibody has the same variable region and constant region sequence as the therapeutic antibody.
What is a Biosimilar antibody?
A Biosimilar antibody is a non-therpeutic, recombinantly-expressed antibody which has the same sequence as the corresponding therapeutic antibody. It is for research use only. The nomenclature of the Biosimilar antibody includes the name of the therapeutic antibody. For example, Catalog # MAB9577 is called Human EGFR (Research Grade CetuxiMab Biosimilar) antibody.
Reviews for Human CD30/TNFRSF8 (Research Grade Brentuximab Biosimilar) Antibody
There are currently no reviews for this product. Be the first to review Human CD30/TNFRSF8 (Research Grade Brentuximab Biosimilar) Antibody and earn rewards!
Have you used Human CD30/TNFRSF8 (Research Grade Brentuximab Biosimilar) Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image